top of page

Welcome to Wave Anesthesia

Restoring Hope

Since getting approved for usage by the FDA in March 2019, ketamine has been a glimpse of hope to patients with treatment-resistant MDD due to its rapid efficacy and relatively less adverse effects in comparison to other antidepressant medications. This has provided some relief to the patients, their families and clinicians.

Image by Stephen Andrews


Call for consultation: 360-723-0872
Or email us at

Monday, Wednesday, Friday

3:00 PM- 7:00 PM

Schedule a consultation or ask about our service.

1706 W Main St. Suite 113, Battle Ground, WA 98604


Thanks for submitting!

Doctor Using Digital Tablet

Provider Referral PDF Form

Click to download the form to submit a patient referral or fill out the online form below.

PDF Referral Form

Online Provider Referral Form

Provider Information

Patient Information

Thank you.

wave logo ketamine.png
Online Referral form
Man Signing


Need a PDF version of our referral form? Download here.

bottom of page